AMA Cites Enzyte Marketer In Call For Stronger Supplement Ad Regulation
This article was originally published in The Tan Sheet
Executive Summary
The American Medical Association is pushing for stronger regulation of herbal supplement advertising based on the concern that some ads looks like promotions for Rx drugs
You may also be interested in...
CSPI Targets OTC Male Enhancement Products With Enzyte FTC Letter
The Federal Trade Commission should immediately enjoin national television ads for Berkeley Premium Nutraceuticals' herbal supplement Enzyte, according to the Center for Science in the Public Interest
FDA/FTC Internet Regulation Of Herbal Supplements Questioned In JAMA
A study finding that about half the websites selling dietary supplements continue to make illegal health claims suggests the regulation of such advertising requires further improvement, the editors of the Journal of the American Medical Association contend in the publication's Sept. 17 edition
Enzyte Male Enhancement Program Claims Overly Enhanced
Lifekey Healthcare should discontinue performance and efficacy claims for its Enzyte Male Enhancement Program, due in part to insufficient clinical evidence of the product's performance and efficacy, the National Advertising Division says